Published Research

Discover our latest scientific contributions, trial findings, and expert presentations shaping the future of early-phase clinical pharmacology, CNS, and analgesia research.

Bunionectomy as an Acute Postoperative Pain Model

A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Interactions Between Alcohol and Sunobinop in Healthy Participants

A Digital Twin-Based Framework for Mitigating Missing Data in Clinical Trials: Application to Anti-Obesity Drug Development

An Open-Label Study on Ulotaront's Effects on Insulin-Glucose Regulation in Schizophrenia Patients with Metabolic Syndrome and Prediabetes

Advancing FDA Guidance on Weight Management Products

Are the Neurocognitive Effects Attributed to Incretin Therapy Centrally or Peripherally Regulated?

Cognitive Outcomes In Adults Treated With GLP-1 Receptor Agonists Compared To Non-Users

Double-Blind Study on Ulotaront's Impact on Weight-Related Parameters

Pharmacodynamic Models as Eearly Predictors of Weight Loss Efficacy in Early-Phase Clinical Research

Non-Invasive Biomarkers of Metabolic Liver Disease

Leading the Future of Obesity Drug Development

Discovery in the Desert

Validation of the NeuroKit Platform for CNS Pharmacodynamic Assessment in Healthy Volunteers

Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer’s disease

Allogeneic Mesenchymal Stem Cell Therapy with Laromestrocel in Mild Alzheimer’s Disease

Endotoxin Challenge: Optimizing Experimental Models for Antipyretic Drug Development

Get in Touch

ERG’s mission is to provide the highest quality clinical trial execution across all clinical research phases to help sponsors.

Contact ERG Join a Study